Search Results 461-470 of 17376 for bisphosphonates side effects

  1. Hematology - Clinical trials

    This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta ...

  2. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

    The purpose of this study is to evaluate the side effects and best dose of AFP464 for treating patients who have solid tumors that are metastatic or ...

  3. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  4. Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... Patients receiving bisphosphonates; Pre-existing conditions. Disorders ...

  5. A Study of How Age Affects Osteoclast Inhibition and Bone Formation - Mayo Clinic

    Bisphosphonates (within the past 3 years); Denosumab; Estrogen (E) therapy within the past year; Treatment with a selective E receptor modulator within the ...

  6. Hematology - Clinical trials

    The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe for patients.

  7. Blood thinners: Can I still get blood clots? - Mayo Clinic

    14, 2022. Leung LLK. Direct oral anticoagulants (DOACs) and parenteral direct-acting anticoagulants: Dosing and adverse effects. https://www.uptodate.com/ ...

  8. Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... Stable, tolerable Grade 2 adverse ... Bisphosphonates and denosumab are permitted if subject has been ...

  9. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...

  10. Anxiety: A cause of high blood pressure? - Mayo Clinic

    Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects. https://www.uptodate.com/contents/search. Accessed Dec ...